CHD
54
-5
TSCO
53
-2
NVDA
63
-2
AEE
58
-2
BRK.B
45
-4
SRCL
37
3
GRMN
43
-3
MRK
48
26
BMY
40
5
BAX
47
3
AKAM
64
-2
MPC
62
32
MU
42
-2
QCOM
60
3
LLY
56
2
AZO
56
-2
ABBV
37
2
CTSH
51
-4
DGX
43
11
ABT
60
-3
CHD
54
-5
TSCO
53
-2
NVDA
63
-2
AEE
58
-2
BRK.B
45
-4
SRCL
37
3
GRMN
43
-3
MRK
48
26
BMY
40
5
BAX
47
3
AKAM
64
-2
MPC
62
32
MU
42
-2
QCOM
60
3
LLY
56
2
AZO
56
-2
ABBV
37
2
CTSH
51
-4
DGX
43
11
ABT
60
-3
Financhill
Back

UroGen Pharma Stock Predictions

The truth about AI stocks (must see)

Learn the names of all 10 stocks here. FREE.
Buy
51

URGN
UroGen Pharma

Last Price:
12.47
Seasonality Move:
5.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Gold Set to Skyrocket as Fed Slashes Rates

Click here for the details on this incredible opportunity.

UroGen Pharma Stock Forecast

  • Over the next 52 weeks, UroGen Pharma has on average historically fallen by 6.7% based on the past 7 years of stock performance.
  • UroGen Pharma has fallen lower in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
  • Is UroGen Pharma Stock Undervalued?
    The current UroGen Pharma [URGN] share price is $12.47. The Score for URGN is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • URGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will UroGen Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, UroGen Pharma has on average historically fallen by 6.7% based on the past 7 years of stock performance.

UroGen Pharma Stock Rating

Buy
51
UroGen Pharma (URGN) is a Buy

Is UroGen Pharma overpriced?

  • UroGen Pharma has fallen lower in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

UroGen Pharma Stock Price History

Is URGN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
urogen.com

52-Week Data

52-Week High:
20.70
52-Week Low:
10.60

Prediction Charts

Market Cap:
525.16M
Price in USD:
12.47
Volume:
368.91K
Beta:
1.13

Technical Analysis

SMA50:
13.41
SMA100:
14.57
SMA200:
14.93
52-Wk Change:
4.88%

Stock Predictions

  • Is UroGen Pharma stock public?
    Yes, UroGen Pharma is a publicly traded company.
  • What is the UroGen Pharma stock quote today?
    The UroGen Pharma stock price is 12.47 USD today.
  • How to buy UroGen Pharma stock online?
    You can buy UroGen Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-2 12.41 12.58 12.80 12.30
Oct-3 12.49 12.40 12.61 12.27
Oct-4 12.49 12.70 12.89 12.43
Oct-7 12.71 12.42 12.74 12.22
Oct-8 12.46 13.11 13.25 12.33
Oct-9 13.00 11.89 13.00 11.30
Oct-10 11.71 11.92 12.15 11.40
Oct-11 11.82 12.60 12.63 11.58
Oct-14 12.94 12.26 13.64 12.18
Oct-15 12.21 12.27 12.31 11.84
Oct-16 12.44 12.60 13.54 12.15
Oct-18 12.88 12.73 13.00 12.43
Oct-21 12.79 12.52 12.82 12.42
Oct-22 12.45 12.47 12.52 12.28

UroGen Pharma Earnings

UroGen Pharma Earnings Report: Per Share UroGen Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

UroGen Pharma Forecast Revenue Growth

UroGen Pharma Stock Analysis: Historical quarterly revenues per share for UroGen Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.62 per share.

* UroGen Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.